Nufarm (NUF) Investor Day 2026 presentation summary
Event summary combining transcript, slides, and related documents.
Investor Day 2026 presentation summary
27 Sep, 2026Strategy and business direction
Portfolio sharpened to focus on crops and segments with clear competitive advantage, reducing investment in commodity products lacking differentiation.
Innovation accessed through partnerships with start-ups, institutions, and universities, lowering technical and commercial risk.
Investment prioritized in high-returning seeds, expansion of carinata with bp, and a measured approach to omega-3.
Emphasis on quality and differentiation over breadth, aligning cost and capital base to focused markets.
Strategy aims for higher, more durable returns through disciplined capital allocation and selective market participation.
Financial performance and guidance
FY26 EBITDA guidance set at $370–380m, representing approximately 25% growth year-over-year.
Leverage targeted at approximately 2.0x, down from 2.7x, with positive free cash flow expected.
$50m cost savings program on track, with full benefit expected by FY28 and majority of savings from cost of goods sold.
Capital expenditure capped under $200m for FY26–FY28, with a focus on efficient allocation and returns above WACC.
Free cash flow improved by $193m year-over-year, with asset optimization and portfolio actions underway.
Crop protection and innovation
Focused investment in differentiated resistance management, biological solutions, and specialty crops.
Three core crop systems prioritized: cereals, trees/nuts/vines, and soybean, representing 46% of the $80b global market.
Near-term pipeline includes products with a total addressable market of ~$8b, with launches planned through 2033.
Regional strategies tailored to strengths: growth in APAC, profitable growth in Europe, and improved returns in North America.
Partnerships drive innovation, enabling capital-efficient growth and access to differentiated products.
Latest events from Nufarm
- Strong margin expansion, disciplined capital allocation, and hybrid seed growth drive future returns.NUF
Life Sciences Virtual Investor Forum - EBITDA up 18%, NPAT up 35%, margins at 20-year high, leverage and CapEx reduced.NUF
H1 2026 - Statutory loss reported, seeds business repositioned, new CEO appointed, all resolutions passed.NUF
AGM 2026 - Crop Protection earnings up 18%, net debt down, FY26 targets EBITDA growth and lower leverage.NUF
H2 2025 - EBITDA down 29%, net debt cut 25%, and omega-3 revenue hit $50M amid tough market conditions.NUF
H2 2024 - AGM addressed FY24 challenges, cost savings, innovation, and strong shareholder support for resolutions.NUF
AGM 2025 - Revenue up 3%, net profit down 39%, Crop Protection strong, no interim dividend declared.NUF
H1 2025